Effect of FOLFOX chemotherapy on gene expression and on the FDG kinetics in a human colorectal cancer cell line

被引：0
|
作者：
Dimitrakopoulou-Strauss, A
Strauss, LG
Koczan, D
Hoffend, J
Thiesen, HJ
Haberkorn, U
机构：
[1] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, D-6900 Heidelberg, Germany
[2] Univ Rostock, Inst Immunol, D-2500 Rostock 1, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2004年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S287 / S287
页数：1
相关论文
共 50 条
  • [21] Xrcc1 or Mthfr Gene: Superior Gene for Predicting a Response during Folfox Chemotherapy for Metastatic Colorectal Cancer
    Kim, Joo Hyung
    Suh, Kwang Wook
    MOLECULAR THERAPY, 2018, 26 (05) : 213 - 213
  • [22] THE EFFECT OF PEGFILGRASTIM ON COMPLETE BLOOD COUNT IN COLORECTAL CANCER PATIENTS TREATED WITH FOLFOX OR FOLFIRI CHEMOTHERAPY
    Kremer, V.
    Shapira, I.
    Leaf, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (03)
  • [23] Gene Expression Profile of Chemotherapy Effect on Human Ewing Sarcoma Cell Lines
    Bui, M. M.
    Fan, C. Y.
    Schichman, S. A.
    Zhang, Y. O.
    Cubitt, C. I.
    Menth, J.
    Zhang, P. J.
    Sullivan, D.
    LABORATORY INVESTIGATION, 2010, 90 : 16A - 16A
  • [24] Gene Expression Profile of Chemotherapy Effect on Human Ewing Sarcoma Cell Lines
    Bui, M. M.
    Fan, C. Y.
    Schichman, S. A.
    Zhang, Y. O.
    Cubiu, C. I.
    Menth, J.
    Zhang, P. J.
    Sullivan, D.
    MODERN PATHOLOGY, 2010, 23 : 16A - 16A
  • [25] Erlotinib in combination with bevacizumab and FOLFOX4 as second-line chemotherapy for patients with metastatic colorectal cancer
    Shi, Sha
    Lu, Kemei
    Gao, Hui
    Sun, Huidong
    Li, Senlin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (09): : 1971 - 1977
  • [26] KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy
    Sharma, Neelesh
    Saifo, Maher
    Tamaskar, Ila R.
    Bhuvaneswari, Ramkumar
    Mashtare, Terry
    Fakih, Marwan
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 1 (02) : 90 - 96
  • [27] Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
    Chua, W.
    Goldstein, D.
    Lee, C. K.
    Dhillon, H.
    Michael, M.
    Mitchell, P.
    Clarke, S. J.
    Iacopetta, B.
    BRITISH JOURNAL OF CANCER, 2009, 101 (06) : 998 - 1004
  • [28] Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
    Ruzzo, Annamaria
    Graziano, Francesco
    Loupakis, Fotios
    Rulli, Eliana
    Canestrari, Emanuele
    Santini, Daniele
    Catalano, Vincenzo
    Ficarelli, Rita
    Maltese, Paolo
    Bisonni, Renato
    Masi, Gianluca
    Schiavon, Gaia
    Giordani, Paolo
    Giustini, Lucio
    Falcone, Alfredo
    Tonini, Giuseppe
    Silva, Rosarita
    Mattioli, Rodolfo
    Floriani, Irene
    Magnani, Mauro
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1247 - 1254
  • [29] PRELIMINARY EFFICACY OF BEVACIZUMAB WITH FIRST LINE CHEMOTHERAPY BY FOLFOX OR FOLFIRI FOR METASTATIC COLORECTAL CANCER (MCRC): AN ALGERIAN EXPERIENCE
    Bensalem, A.
    Bouzid, K.
    ANNALS OF ONCOLOGY, 2009, 20 : 40 - 40
  • [30] Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
    W Chua
    D Goldstein
    C K Lee
    H Dhillon
    M Michael
    P Mitchell
    S J Clarke
    B Iacopetta
    British Journal of Cancer, 2009, 101 : 998 - 1004
12345